» Articles » PMID: 39042290

MicroRNAs Role in Telomere Length Maintenance and Telomerase Activity in Tumor Cells

Overview
Specialty General Medicine
Date 2024 Jul 23
PMID 39042290
Authors
Affiliations
Soon will be listed here.
Abstract

MiRNAs, a class of non-coding RNA molecules, have emerged as critical modulators of telomere length and telomerase activity by finely tuning the expression of target genes (and not gene targets) within signaling pathways involved in telomere homeostasis. The primary objective of this systematic review was to compile and synthesize the existing body of knowledge on the role, association, and involvement of miRNAs in telomere length. Additionally, the review explored the regulation, function, and activation mechanism of the human telomerase reverse transcriptase (hTERT) gene and telomerase activity in tumor cells. A comprehensive analysis of 47 selected articles revealed 40 distinct miRNAs involved in these processes. These miRNAs were shown to exert their function, in both clinical cases and cell line models, either directly or indirectly, regulating hTERT and telomerase activity through distinct molecular mechanisms. The regulatory roles of these miRNAs significantly affected major cancer phenotypes, with outcomes largely dependent on the tissue type and the cellular actions within the tumor cells, whereby they functioned as oncogenes or tumor suppressors. These findings strongly support the pivotal role of miRNAs in modulating telomere length and telomerase activity, thereby contributing to the intricate and complex regulation of telomere homeostasis in tumor cells. Moreover, they emphasize the potential of targeting miRNAs and key regulatory genes as therapeutic strategies to disrupt cancer cell growth and promote senescence, offering promising avenues for novel cancer treatments.

Citing Articles

Research Progress on Natural Products That Regulate miRNAs in the Treatment of Osteosarcoma.

Wang L, Liu X, Lv H, Zhang H, Lin R, Xu S Biology (Basel). 2025; 14(1).

PMID: 39857292 PMC: 11759184. DOI: 10.3390/biology14010061.

References
1.
Blackburn E . Switching and signaling at the telomere. Cell. 2001; 106(6):661-73. DOI: 10.1016/s0092-8674(01)00492-5. View

2.
Azzalin C, Reichenbach P, Khoriauli L, Giulotto E, Lingner J . Telomeric repeat containing RNA and RNA surveillance factors at mammalian chromosome ends. Science. 2007; 318(5851):798-801. DOI: 10.1126/science.1147182. View

3.
Palm W, de Lange T . How shelterin protects mammalian telomeres. Annu Rev Genet. 2008; 42:301-34. DOI: 10.1146/annurev.genet.41.110306.130350. View

4.
Harley C, Futcher A, Greider C . Telomeres shorten during ageing of human fibroblasts. Nature. 1990; 345(6274):458-60. DOI: 10.1038/345458a0. View

5.
Crompton N . Telomeres, senescence and cellular radiation response. Cell Mol Life Sci. 1997; 53(7):568-75. PMC: 11147279. DOI: 10.1007/s000180050073. View